Document is current
Any future updates will be listed below
-
Authors
,
Hosoda, Kiminori
Nishimura, Kunihiro
Miyamoto, Yoshihiro
Murata, Takashi
Sakane, Naoki
Satoh-Asahara, Noriko
Toyoda, Masao
Hirota, Yushi
Matsuhisa, Munehide
Kuroda, Akio
Kato, Ken
Kouyama, Ryuji
Miura, Junnosuke
Tone, Atsuhito
Kasahara, Masato
Kasama, Shu
Suzuki, Shota
Ito, Yukie
Watanabe, Tomokazu
Suganuma, Akiko
Shen, Zhuo
Kobayashi, Hiroko
Takagi, Satoshi
Hoshina, Sari
Shimura, Kanako
Tsuchida, Yukiko
Kimura, Moritsugu
Saito, Nobumichi
Shimada, Akira
Oikawa, Yoichi
Satomura, Atsushi
Haisa, Akifumi
Kawashima, Satoshi
Meguro, Shu
Itoh, Hiroshi
Saisho, Yoshifumi
Irie, Junichiro
Tanaka, Masami
Mitsuishi, Masanori
Nakajima, Yuya
Inaishi, Jun
Kinouchi, Kenichiro
Yamaguchi, Shintaro
Itoh, Arata
Sugiyama, Kazutoshi
Yagi, Kazuma
Tsuchiya, Tami
Kodani, Noriko
Shimizu, Ikki
Fukuda, Tetsuya
Kusunoki, Yoshiki
Katsuno, Tomoyuki
Matoba, Yuka
Hitaka, Yumi
Abe, Kentaro
Tanaka, Natsuko
Taniguchi, Ryoko
Nagao, Toshihiko
Hida, Kazuyuki
Iseda, Izumi
Takeda, Masaya
Matsushita, Yuichi
Tenta, Masafumi
Tanaka, Tsuyoshi
Kouyama, Kunichi
Fukunaga, Michiru
Murata, Takashi https://orcid.org/0000-0001-8634-9657
Hirota, Yushi
Hosoda, Kiminori
Kato, Ken
Kouyama, Kunichi
Kouyama, Ryuji
Kuroda, Akio
Matoba, Yuka
Matsuhisa, Munehide
Meguro, Shu
Miura, Junnosuke
Nishimura, Kunihiro
Sakane, Naoki
Shimada, Akira
Suzuki, Shota
Tone, Atsuhito
Toyoda, Masao
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18ek0210104h0001, 19ek0210104h0002, 20ek0210104h0003)
Japan IDDM network (Not available.)
- License Information
-
More Information
Article History
Received: 15 February 2023
Accepted: 30 November 2023
First Online: 15 February 2024
Declarations
:
: No potential conflicts of interest (COI) as the ISCHIA Study Group relevant to this article were reported. Potential COI concerning all individual investigators were reviewed by the Certified Review Board in accordance with the Clinical Trials Act []. The COI of the members of the writing group are as follows: YH received lecture fee from Abbott, Eli Lilly, Sanofi, Sumitomo and Terumo and received research grant from Sumitomo. AK received lecture fee from Eli Lilly. MM received lecture fee from Abbott, Eli Lilly, Novo Nordisk and Sanofi, and received research grant from Novo Nordisk. SM received lecture fee from Boehringer Ingelheim, Eli Lilly and Novo Nordisk. JM received lecture fee from Terumo. AS received lecture fee from Abbott and Terumo. AT received lecture fee from Abbott, Eli Lilly, Sanofi and Terumo. MT received lecture fee from Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sumitomo and received subsidies from Cocokara Fine Healthcare, LifeScan, Roche DC and Super Light Water. TM, KH, K Kato, K Koyama, RK, YM, JM, KN, NS and SS declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and/or with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study. The study protocol was approved by the Certified Review Board (National Hospital Organization Osaka National Hospital: N2018002). Clinical trial registration: jRCT1052180075 (approval date of registry; 26 February 2019).
